Edwards Lifesciences News

WASHINGTON, DC, October 13 / MARKET WIRE/ -- Edwards Lifesciences Corporation , the world leader in the science of heart valves, announced that new data from two studies of the Edwards SAPIEN transcatheter ...

The drug maker scored a legal victory as a federal court in Boston upheld a jury decision backing Amgen 's patents for 2 anemia drugs, Epogen and Aranesp.

The UConn Foundation, which manages the university's $400 million endowment, has lost roughly $32 million so far this year.

LOS ANGELES and SHENZHEN, China, Sept. 22 SIHI-Names-Tracy-CFO and SHENZHEN, China , /Xinhua-PRNewswire/ -- SinoHub, Inc.

Job Description: Edwards Lifesciences is a global leader in products and technologies to treat advanced cardiovascular disease, the global leader in acute hemodynamic monitoring and the number-one heart valve ...

A tag cloud is a visual list of key terms associated with a piece of content. Larger and bolder tags are more relevant to the content.

Q : My shares of Meridian Growth Fund seem to be doing OK but not great. What does the future look like? M.R. A : Tamer than "go-go" growth funds, it has reasonable fees, an experienced portfolio manager and a ...

Main Category: Cardiovascular / Cardiology Also Included In: Medical Devices / Diagnostics ; Regulatory Affairs / Drug Approvals Article Date: 04 Sep 2008 - 5:00 PDT Edwards Lifesciences Corporation , the world ...

By Debra Sherman

CHICAGO (Reuters) - Edwards Lifesciences Corp said on Wednesday that it won U.S. regulatory approval for a device to replace diseased mitral valves, one of the most common forms of heart valve abnormalities.

Approval from the U.S. Food and Drug Administration, eagerly awaited by investors after numerous delays, boosted Edwards' stock on hopes that it will help the heart valve maker reverse recent market share losses.

Edwards' Perimount Magna mitral valve will be launched in the United States immediately, making Edwards the only company to have a bovine pericardial mitral valve replacement on the U.S. market.

A long-planned closure of Allergan Inc. 's Fremont collagen manufacturing facility is slated to be complete by Oct.

Edwards Lifesciences Corp. July 22, 2008, 05:00 PM ET Executives David K. Erickson - VP, IR Michael A. Mussallem - Chairman and CEO Thomas M. Abate - Corporate VP, CFO and Treasurer Larry L. Wood - Corporate ...

The biotech said Q2 EPS rose 30% to 91 cents ex items, beating views by 6 cents.

Edwards Lifesciences Corp., the maker of a heart valve implanted without chest-splitting surgery, may be a ripe acquisition target for the world's two biggest device makers, including Medtronic Inc., analysts ...

Fixing hearts from the inside out -- On Nov. 26, 2007, doctors at the Cedars-Sinai Heart Institute performed the first "transcatheter" minimally invasive replacement of an aortic heart valve in the western ...

The U.S. medical device industry's worst short-term fear may be actor Dennis Quaid.

On Nov. 26, 2007, doctors at the Cedars-Sinai Heart Institute performed the first "transcatheter" minimally invasive replacement of an aortic heart valve in the western United States, using the SAPIEN ...

The U.S. medical device industry's worst short-term fear may be actor Dennis Quaid.

Job Description: This is an outstanding opportunity to lead the development of ground breaking medical devices that are poised to revolutionize cardiac surgery.

Singh v. Edwards Lifesciences Corp. , Wash., Snohomish Co. Super., No. 05-2-12213-5, Mar.

Edwards Lifesciences Corp., which makes heart valves and other medical devices, spent over $167,000 lobbying the federal government in the first quarter, according to a government disclosure form.